A Philadelphia jury has directed US drug agency Johnson & Johnson to pay $8 billion to a man who claims to have developed breasts by utilizing the medicine manufactured by the corporate, in accordance to a report in Forbes. This is a recent authorized affront for the corporate, which has been mired in authorized controversies for some time now. Nicholas Murray, a Maryland resident, has alleged in his lawsuit that after taking their drug Risperdal from 2003 to 2008, he developed gynecomastia, a situation which triggered him to develop breasts.
Risperdal is usually prescribed to these affected by schizophrenia and bipolar dysfunction. According to the report, he was prescribed the drug as he confronted issue in sleeping, principally brought on by autism. In his lawsuit, he has claimed that the corporate was conscious of the danger of gynecomastia, however didn’t warn the docs or the healthcare suppliers. Amid all this, the agency’s spokesperson has said that they’re assured the award can be overturned and that they have been stopped from placing forth “a meaningful defence” on the trial.
“This award for a single plaintiff stands in stark contrast with the initial $680,000 compensatory award and is a clear violation of due process. United States Supreme Court precedent dictates that punitive damages awards that are a double-digit multiplier of the compensatory award should be set aside,” the spokesperson stated.